本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Merrimack Pharmaceuticals

15.13
0.0000
成交量:- -
成交额:- -
市值:2.24亿
市盈率:1.08
高:15.13
开:15.13
低:15.13
收:15.13
数据加载中...
2020/07/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/07/24

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/28

重要事件披露

8-K - Current report
2020/05/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/03/30

重要事件披露

Current report, items 1.01, 2.01, and 9.01
2020/03/13

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/03/12

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/21

重要事件披露

Current report, item 5.08
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/03

重要事件披露

Current report, items 1.01, 3.03, 5.03, and 9.01
2019/11/19

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/11/12

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/10/21

重要事件披露

Current report, item 5.07
2019/09/30

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/30

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/26

SEC问询函

[Cover]Correspondence
2019/09/24

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/20

重要事件披露

Current report, items 1.01, 5.02, and 9.01